Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in 1-12 Year-old Gabonese Children Naturally Exposed to Malaria Parasites
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2018
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary)
- Indications Falciparum malaria
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanaria
- 25 Jul 2018 Status changed from active, no longer recruiting to recruiting.
- 26 Jun 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 15 Jun 2018 Planned initiation date changed from 1 May 2018 to 1 Jun 2018.